Who owns RTI Biologics?

Key details on RTI Biologics (Ticker: RTIX)

Who owns RTI Biologics?

Is RTIX a good stock to own? Find out who bought RTI Biologics, who sold RTI Biologics (RTIX) stock, and who holds a large position in RTI Biologics.

Fund Name Number of Shares Share Valuation As Of
Paradigm Capital Management 4.41M $22.94M Dec. 31, 2014
DIMENSIONAL FUND ADVISORS 3.25M $16.89M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 2.84M $14.78M Dec. 31, 2014
HILLMAN 2.68M $13.95M Dec. 31, 2014
KOPP FUNDS 2.17M $7.67M Dec. 31, 2013
Tamarack Capital Management 2.02M $10.49M Dec. 31, 2014
Frank Russell Company 1.86M $9.76M Dec. 31, 2014
Rock Springs Capital Management 1.86M $9.67M Dec. 31, 2014
GAGNON SECURITIES 1.84M $9.57M Dec. 31, 2014
Royce & Associates 1.79M $9.31M Dec. 31, 2014
Krensavage Asset Management 1.65M $8.59M Dec. 31, 2014
Kopp Investment Advisors 1.62M $8.45M Dec. 31, 2014
Vanguard 1.61M $8.35M Dec. 31, 2014
Fort Washington Investment Advisors 1.58M $5.92M June 30, 2013
BlackRock Fund Advisors 1.56M $8.10M Dec. 31, 2014
Signia Capital Management 1.50M $5.91M March 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.46M $5.94M March 31, 2014
First Light Asset Management 1.41M $7.35M Dec. 31, 2014
Millennium Management 1.40M $5.71M March 31, 2014
KENNEDY CAPITAL MANAGEMENT 1.25M $6.52M Dec. 31, 2014
Principal Financial 1.22M $5.06M Sept. 30, 2012
STATE STREET CORPORATION 1.21M $5.16M Dec. 31, 2013

Who sold RTI Biologics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Accipiter Capital Management June 30, 2011 1.75M $4.74M
Manulife Asset Management June 30, 2011 1.42M $3.84M
FMR Dec. 31, 2010 8.21M $21.92M